ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 178,54
0,18%
Dow Jones
44 546,08
-0,37%
DAX
22 513,42
-0,43%
Brent Oil
74,205
-0,25%
Bitcoin
96 089,37
-1,54%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Cue Biopharma Inc (CUE)

  7. Cue Biopharma Inc (CUE) Actualités

CUE

Cue Biopharma (CUE)

Cue Biopharma Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CUE
DateHeureSourceTitreSymboleSociété
03/01/202522h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
29/11/202422h30GlobeNewswire Inc.Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CUECue Biopharma Inc
29/11/202422h00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
25/11/202414h00GlobeNewswire Inc.Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:CUECue Biopharma Inc
14/11/202422h05GlobeNewswire Inc.Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:CUECue Biopharma Inc
14/11/202422h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CUECue Biopharma Inc
14/11/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CUECue Biopharma Inc
14/11/202414h00GlobeNewswire Inc.Cue Biopharma Announces Strategic Organizational TransitionNASDAQ:CUECue Biopharma Inc
12/11/202414h00GlobeNewswire Inc.Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare ConferenceNASDAQ:CUECue Biopharma Inc
08/11/202419h30GlobeNewswire Inc.Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual MeetingNASDAQ:CUECue Biopharma Inc
07/10/202423h07Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CUECue Biopharma Inc
04/10/202415h00GlobeNewswire Inc.Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual MeetingNASDAQ:CUECue Biopharma Inc
27/09/202422h05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CUECue Biopharma Inc
27/09/202405h26GlobeNewswire Inc.Cue Biopharma Announces Pricing of $12.0 Million Public OfferingNASDAQ:CUECue Biopharma Inc
27/09/202405h10GlobeNewswire Inc.Cue Biopharma Announces Proposed Public OfferingNASDAQ:CUECue Biopharma Inc
10/09/202422h00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CUECue Biopharma Inc
09/09/202414h00GlobeNewswire Inc.Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business OfficerNASDAQ:CUECue Biopharma Inc
03/09/202414h00GlobeNewswire Inc.Cue Biopharma to Present at The Promise of Interleukin-2 Therapy ConferenceNASDAQ:CUECue Biopharma Inc
28/08/202422h00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:CUECue Biopharma Inc
19/08/202422h05GlobeNewswire Inc.Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:CUECue Biopharma Inc
13/08/202414h00GlobeNewswire Inc.Cue Biopharma to Host Business Update Call and WebcastNASDAQ:CUECue Biopharma Inc
25/07/202422h05GlobeNewswire Inc.Cue Biopharma Announces Strategic Prioritization of Autoimmune Programs Enabling Optimization of Workforce and Reduction of Capital RequirementsNASDAQ:CUECue Biopharma Inc
04/06/202414h00GlobeNewswire Inc.Cue Biopharma Presents Updated Data from Phase 1 Trial of CUE-101 in Recurrent/Metastatic HPV+ Head and Neck Cancer at the 2024 ASCO Annual MeetingNASDAQ:CUECue Biopharma Inc
03/06/202414h00GlobeNewswire Inc.Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in June 2024NASDAQ:CUECue Biopharma Inc
24/05/202422h00Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CUECue Biopharma Inc
09/05/202422h05GlobeNewswire Inc.Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:CUECue Biopharma Inc
08/05/202414h00GlobeNewswire Inc.Cue Biopharma to Present at the 20th Annual PEGS Boston SummitNASDAQ:CUECue Biopharma Inc
07/05/202414h00GlobeNewswire Inc.Cue Biopharma to Participate in Fireside Chat at The Citizens JMP Life Sciences ConferenceNASDAQ:CUECue Biopharma Inc
24/04/202416h01GlobeNewswire Inc.Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CUECue Biopharma Inc
08/04/202422h05GlobeNewswire Inc.Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business HighlightsNASDAQ:CUECue Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:CUE

Dernières Valeurs Consultées

SPI
SP500
S&P 500
EU
RNO
Renault
COIN
AVAXUSD
Avalanche
FTSE
UKX
FTSE 100
EU
CAP
Capgemini
USI
USTECH100
US Tech 100
EU
ORA
Orange
EU
GLE
Societe Generale
COIN
SOLUSD
Solana
EU
LR
Legrand
EU
MC
Lvmh Moet Hennessy Louis...
EU
ML
Michelin
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces